Fund shareholders of INSIGHT MOLECULAR DIAGNOSTICS
ISIN US68235C2061 · United States · LEI 549300BIYAW8GO410287
- Fund shareholders
- 10
- Of which ETFs
- 1 9 other funds
- Value held
- 3.1M $
- Share of capital
- 2.3 % of 32.7M shares on Aug 3, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 297,775 | 976.7K $ | 0.91 % | as of Mar 31, 2026 ↗ | |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 231,459 | 759.2K $ | 0.00 % | 0.71 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 116,166 | 698.2K $ | 0.00 % | 0.35 % | as of Feb 28, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 38,652 | 232.3K $ | 0.00 % | 0.12 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 31,029 | 186.5K $ | 0.00 % | 0.09 % | as of Feb 28, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 28,842 | 94.6K $ | 0.01 % | 0.09 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 10,615 | 63.8K $ | 0.00 % | 0.03 % | as of Feb 28, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 7,927 | 26K $ | 0.02 % | as of Mar 31, 2026 ↗ | |
| Victory Extended Market Index Fund Victory Portfolios III | 3,200 | 12.8K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 2,330 | 7.6K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| iShares Micro-Cap ETF iShares Trust | 0.01 % | as of Mar 31, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 0.00 % | as of Apr 30, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 10 | 0 | 767,995 | +20.6 % |
| 2026Q1 | 10 | +1 | 636,582 | +16.7 % |
| 2025Q4 | 9 | 0 | 545,658 | -16.2 % |
| 2025Q3 | 9 | +1 | 651,454 | +62.0 % |
| 2025Q2 | 8 | 0 | 402,225 | +12.9 % |
| 2025Q1 | 8 | -5 | 356,259 | -0.1 % |
| 2024Q4 | 13 | +6 | 356,679 | +18.9 % |
| 2024Q3 | 7 | -4 | 299,996 | -2.5 % |
| 2024Q2 | 11 | 0 | 307,561 | +0.3 % |
| 2024Q1 | 11 | 0 | 306,744 | +2.5 % |
| 2023Q4 | 11 | 299,346 |
Institutional managers
38 managers declare this company to the SEC (Form 13F); the 25 largest follow.
| Manager | Shares | Value | |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 11,931,839 | 39.1M $ | as of Mar 31, 2026 |
| AWM Investment Company, Inc. | 2,806,256 | 9.2M $ | as of Mar 31, 2026 |
| PURA VIDA INVESTMENTS, LLC | 947,134 | 3.1M $ | as of Mar 31, 2026 |
| Alyeska Investment Group, L.P. | 840,777 | 2.8M $ | as of Mar 31, 2026 |
| HEIGHTS CAPITAL MANAGEMENT, INC | 392,545 | 1.3M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 262,053 | 860.2K $ | as of Mar 31, 2026 |
| FNY Investment Advisers, LLC | 247,421 | 811 $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 135,345 | 443.9K $ | as of Mar 31, 2026 |
| Family Office Research LLC | 127,266 | 417.4K $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 103,470 | 339.4K $ | as of Mar 31, 2026 |
| Ghisallo Capital Management LLC | 70,695 | 231.9K $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 56,093 | 184K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 50,754 | 166.5K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 49,090 | 161K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 36,088 | 118.4K $ | as of Mar 31, 2026 |
| XTX Topco Ltd | 30,353 | 99.6K $ | as of Mar 31, 2026 |
| 683 Capital Management, LLC | 29,000 | 95.1K $ | as of Mar 31, 2026 |
| Qube Research & Technologies Ltd | 25,230 | 82.8K $ | as of Mar 31, 2026 |
| OSAIC HOLDINGS, INC. | 24,135 | 79.2K $ | as of Mar 31, 2026 |
| UBS Group AG | 22,751 | 74.6K $ | as of Mar 31, 2026 |
| Engineers Gate Manager LP | 18,253 | 59.9K $ | as of Mar 31, 2026 |
| Flatrock Wealth Partners LLC | 13,044 | 42.8K $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 12,250 | 40.2K $ | as of Mar 31, 2026 |
| OMERS ADMINISTRATION Corp | 10,500 | 34.4K $ | as of Mar 31, 2026 |
| Private Advisor Group, LLC | 10,416 | 34.2K $ | as of Mar 31, 2026 |
Declared shareholders of INSIGHT MOLECULAR DIAGNOSTICS
1 beneficial ownership filing. These stakes do not add up: an asset manager filing aggregates its own funds, already counted above.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Broadwood Partners, L.P. and 2 others | 39.70 % | 12,835,134 | as of Apr 23, 2026 · SCHEDULE 13D |
Cite this page
Titelia. "Fund shareholders of INSIGHT MOLECULAR DIAGNOSTICS". https://titelia.com/en/stocks/insight-molecular-diagnostics-US68235C2061